Abstract
Objective:Trace elements play a significant role in several metabolic processes and often circulate in the blood binding to protein. The purpose of this study was to determine the status of selenium, zinc, and boron in idiopathic nephrotic syndrome patients in active and remission phases.
Materials and Methods: Fourteen patients and fourteen healthy age-matched controls were included in the study. The selenium, zinc and boron level in plasma and urine were measured by the inductively coupled plasma mass spectrometry.
Results: The plasma levels of zinc and selenium were significantly lower in both active and remission patients (for all p=0.0001). The plasma boron level was significantly lower only in patients in active phase (p=0.0002 vs control). The concentrations of urinary boron and selenium were significantly higher during active phase compared with remission (p=0.0003 and 0.0001, respectively).
Conclusion: Supplementation with zinc, selenium and boron may be justified in patients suffering with this disease.
Keywords: Boron, children, nephrotic syndrome, selenium, zinc
Özet
Amaç: Eser elementler birçok metabolik süreçte yer ahr ve siklikla proteine baglanarakdolajirlar. Bu çalismada nefrotik sendromlu hastalarin aktivasyon ve remisyon dönemlerinde selenyum, çinko ve bor durumlarinin arastirilmasi amaçlanmistir.
Gereç ve Yöntem: Ondört hasta ve 14 saglikli, benzer yasta kontrol grubu çalismaya alindi. Plazma ve Idrarda selenyum, çinko ve bor düzeyleri indükleyici çiftlesmis plazma kitle spektrometri Ile ölçüldü.
Bulgular: Plazma çinko ve selenyum düzeyleri hem aktivasyon hem de remisyon döneminde anlamli olarak düsük bulundu (hepsi için p=0,0001). Plazma bordüzeyl sadece aktivasyon döneminde anlamli olarakdüjüktü (p=0,0002, kontrol Ile karsilastirildiginda). Id rar bor ve selenyum düzeyleri aktivasyon döneminde remisyon dönemine kiyasla anlamli olarakyüksektl (p=0,0003 ve 0,0001, sirasiyla).
Sonuç: Nefrotik sendromlu hastalarin çinko, selenyum ve bor açisindan desteklenmesi gerekebilir.
Anahtar Kelimeler: Bor, çinko, çocuklar, nefrotiksendrom, selenyum
Introduction
Trace elements play a significant role in several metabolic processes and often circulate in the blood binding to protein. Their deficiency can adversely affect children who are in the process of growth and development [1]. Zinc is known to be an essential element and is involved the structure of about 120 enzymes such as DNA polymerase, reverse transcriptase and RNA polymerase [2]. Selenium is also an essential element and also has an important role in gene transcription, antioxidant system, thyroid hormone metabolism and immune system [1, 3]. Boron, which is another trace element, influences the hormones functioning energy and mineral metabolism, including thyroid hormone, vitamin D and insulin. It has been shown that boron has beneficial effects on bone health, immune system and some cancers. In addition, boron has favorable effects on brain functions. It is thought that boron is necessary for membrane integrity and cell function [4,5],
Idiopathic nephrotic syndrome (INS) is one of the most common renal diseases in the pediatric age group and it is characterized by hypoalbuminemia, hyperlipidemia and proteinuria [6],There are few studies investigating the level of trace elements in the nephrotic NS during childhood and the results of these studies are somewhat contradictory in terms of some trace elements [7-9]. our knowledge, there is no study investigating the level of boron in the NS patients. The aim of this study was to investigate the status of trace element selenium, zinc, and boron of INS patients in active and remission phase.
Materials and Methods
The study was approved by the ethics committee of the Erciyes University, and informed consent was obtained from all families before study entry. The research conformed to all the ethical requirements of the Helsinki declaration.
This prospective study was conducted between January 2007 and March 2008. Children with NS without renal failure or systemic disease were included in the study. Fourteen patients with INS suffering from their initial episode or during a relapse, with a mean age of 8.5±4.9 10 males and 4 females were included in the study. The control group was consisted of 14 age-matched (8 males, 6 females) healthy children.
Blood and urine samples were taken from children with NS both in active phase of NS and remission. Only blood samples were taken from healthy children. The samples from patients in active phase were obtained before starting steroid. Active NS was defined as serum albumin concentration below 2.5 g/dL and urinary protein excretion above 40 mg/m2 per hour with high cholesterol levels. Remission was defined as no proteinuria using the colorimetric qualitative test and a urinary protein/creatinine ratio of <0.2 on a random urine sample. Blood samples were collected from the venous vein. After centrifugation plasma samples were stored at -80°C, while urine samples were stored at -26°C until analysis.
The plasma and urine levels of boron, zinc and selenium were measured by inductively coupled plasma mass spectrometry (Agilent 7500a; Agilent Technologies, Stockport, UK). Results were expressed as μg/L.
Statistical analysis
Statistical analysis was performed using the Version 15.0 of Statistical Package for the Social Sciences (SPSS) for Windows. Determinations of distributional normality were tested by using the Shapiro-Wilk test. Data are presented as mean±SD. For trace elements in plasma, different between groups were determined using the Student's f test or paired samples f test. For trace elements in urine, differences between paired samples in remission and active phase were determined using paired samples t-test. The comparisons of proportions were performed with the χ2-test. All tests were considered as statistically significant if p values were <0.05.
Results
There were no statistical differences between both groups regarding gender distribution (p=0.2).
Plasma boron, zinc and selenium levels of the NS group in active phase were significantly lower than in the control group (p=0.0003, p=0.0001 and p=0.0001, respectively). Plasma zinc and selenium levels had not returned to normal levels during the remission.There was no statistical difference between INS group in remission and control group in terms of boron levels (117±32 vs 136±41 pig/L, p=0.2). Plasma boron and selenium levels were markedly decreased during active phase compared to remission (73.6±37.4 vs 117.2±32.2, p=0.002 and 39.9±7.3 vs 54.8±4.5, p=0.001, respectively) (Figure 1).
The concentrations of urinary boron and selenium were significantly higher during active phase compared to remission (1658±264 vs 1106±331 μg/L, p=0.0003 and 20.9±5 vs 8.6±2.6 μg/L, p=0.0001, respectively). No statistically significant difference was noted between urinary zinc of NS patients in remission and in active phase ( 133±107 vs 191 ± 143 μg/L, p=0.2) (Figure 2).
Discussion
In this study, we evaluated the status of boron, selenium and zinc in children with INS. We demonstrated in active phase of INS, plasma boron and selenium concentrations were different from remission period.
Plasma boron level of the NS group in active phase was found to be lower than in remission period and in control group. According to our knowledge this is the first study to examine the status of boron in NS. An experimental recent study reported that boron deficiency causes an increase in the level of homocysteine [10]. In another experimental study, podocyte injury was observed in rats with hyperhomocysteinemia [11]. Hyperhomocysteinemia is known to be a risk factor for venous thromboembolism [12]. In a study conducted on adults, homocysteine levels were found higher in patients with NS [13],Thromboembolism, especially venous thromboembolism, isan important complication in nephroticchildren. It is believed that incidence of thromboembolism has been associated with severe hypoalbuminemia and proteinuria in NS [6]. Hunt et al. [14] demonstrated that supplementation of boron temporarily decreased albuminuria in rat model of diabetes mellitus. Perhaps boron supplementation may reduce albuminuria and thromboembolic complications in NS.
Selenium is an important constituent of glutathione peroxidase enzyme and its deficiency resulting in a marked decline in glutathione peroxidase activity of many tissues, which leads to increased oxidative stress [15]. We found that plasma selenium levels were low in NS patients during both active and remission phase and plasma selenium level had a tendency to return to normal in remission, this is in good agreement with the results of selenium published by Mishra et al. [9]. Additionally, we found that plasma zinc level was lower in the NS group in active and remission phase, which is in good agreement with the results published by Reimold [16] and Perrone et al. [7], but not with those of Mishra et al. [9], who observed no difference between NS and control groups in terms of plasma zinc level. Furthermore, in an experimental study, low serum v and high urinary zinc excretion were observed in nephrotic rats [17],There are studies reporting an impaired oxidant-antioxidant balance in children with NS [8,9,18], Fujieda et al. [19] observed that the decrease of glutathione peroxidase activity, pronounced proteinuria, and glycosuria occurred in rats fed selenium-deficient diet. Recently, it has been observed that alone or combined supplementation of selenium and zinc in diabetic rats improved antioxidant status and decreased lipid peroxidation both in the liver and kidney tissues [20]. Furthermore, it was observed that supplementation of zinc-reduced relapses in children with NS [21].
In our study, urinary excretions of selenium and boron were higher in active period compared to remission phase. Furthermore, plasma concentrations of these trace elements were lower in active phase than in remission period. According to our study findings, it can be speculated that one of the causes of decreased systemic selenium and boron levels is the increased renal excretion of these elements.
The current study had some limitations. First, the number of patients and controls was small. Furthermore, we did not measure the urinary levels of trace elements in controls.
In conclusion, our data show that the plasma levels of boron, selenium and zinc in children with NS lower than in healthy children. In light of these results, the supplementation of these trace elements may be considered in patients with NS. Further studies with larger numbers of patients are warranted to assess the beneficial effects of these trace elements supplementation in this patient group.
Ethics Committee Approval: Ethics committee approval was received for this study from the ethics committee of Erciyes University.
Informed Consent: Written informed consent was obtained from parents of the patients who participated in this study.
Peer-review: Externally peer-reviewed.
Author Contributions: Concept - Z.G., R.D., M.H.P.; Design - Z.G., R.D., M.H.P.; Supervision - Z.G. Funding - Z.G.; Materials - i.D., S.T., F.B.; Data Collection and/or Processing - i.D., S.T., F.B.; Analysis and/or Interpre- tation - U.S., M.H.P., S.T.; Literature Review - S.T.; Writing - S.T.; Critical Review - Z.G.
Conflict of Interest: No conflict of Interest was declared by the authors.
Financial Disclosure: This study was supported financially by the Erciyes University Research Fund.
References
1. Stein AJ. Global impacts of human mineral malnutrition. Plant Soil 2009; 335:133-54. [CrossRef]
2. Jeejeebhoy K. Zinc: an essential trace element for parenteral nutrition. Gastroenterology 2009; 137: 7-12. [CrossRef]
3. Tanguy S, Grauzam S, de Leiris J, et al. Impact of dietary selenium intake on cardiac health: experimental approaches and human studies. Mol Nutr Food Res 2012; 56:1106-21. [CrossRef]
4. Nielsen FH and MeachamSL.Growing Evidence for Human Health Benefits of Boron. Journal of Evidence-Based Complementary & Alternative Medicine 2011 ; 16:169-80. [CrossRef]
5. Hunt CD. Dietary boron: progress in establishing essential roles in human physiology. J Trace Elem Med Biol 2012; 26:157-60. [CrossRef]
6. Niaudet P, Boyer O. Idiopathic Nephrotic Syndrome in Children: Clinical Aspects. In: Avner ED, Harmon WE, Niaudet P,Yoshikawa N, eds, Pediatric Nephrology. 6th Edn. Springer, Berlin, 2009;pp. 667-702. [CrossRef]
7. Perrone L, Gialanella G, Giordano V, et al. Impaired zinc metabolic status in children affected by idiopathic nephrotic syndrome. EurJ Pediatr 1990; 149: 438-40. [CrossRef]
8. Fydryk J, Olszewska M, Urasinski T, et al. Serum selenium level and glutathione peroxidase activity in steroid-sensitive nephrotic syndrome. Pediatr Nephrol 2003; 18:1063-5. [CrossRef]
9. Mishra OP, Gupta AK, Prasad R, et al. Antioxidant status of children with idiopathic nephrotic syndrome. Pediatr Nephrol 2011; 26: 251-6. [CrossRef]
10. NielsenFH.BorondeprivationdecreasesliverS-adenosylmethionine and spermidine and increases plasma homocysteine and cysteine in rats. J Trace Elem Med Biol 2009; 23:204-13. [CrossRef]
11. Yi F, dos Santos EA, Xia M, et al. Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats. Am J Nephrol 2007; 27:262-8. [CrossRef]
12. Bhojwani D, Hart D. Thrombophilia in childhoold. Current Problems in Pediatric and Adolescent Health Care 2004; 34:190212. [CrossRef]
13. Podda GM, Lussana F, Moroni G, et al. Abnormalities of homocysteine and B vitamins In the nephrotic syndrome. Thrombosis Research 2007; 120:647-52. [CrossRef]
14. Hunt CD, Herbel JL. Effects of dietary boron on calcium and mineral metabolism in the streptozotocin-injected, vitamin D3-deprived rat. Magnes Trace Elem 1991-1992; 10: 387-408.
15. Shenkin A. Selenium in Intravenous Nutrition. Gastroenterology 2009;137:61-9. [CrossRef]
16. Reimold EW. Changes in zinc metabolism during the course of the nephrotic syndrome. Am J Dis Child 1980; 134:46-50.
17. Pedraza-Chaverrí J, Torres-Rodríguez GA, Cruz C, et al. Copper and zinc metabolism in aminonucleoside-induced nephrotic syndrome. Nephron 1994; 66:87-92. [CrossRef]
18. Bakr A, Abul Hassan S, Shoker M, et al. Oxidant stress in primary nephrotic syndrome: does it modulate the response to corticosteroids? Pediatr Nephrol 2009; 24: 2375-80. [CrossRef]
19. Fujieda M, Naruse K, Hamauzu T, et al. Effect of selenium-deficient diet on tubular epithelium in normal rats. Pediatr Nephrol 2007; 22:192-201. [CrossRef]
20. Ukperoro JU, Offiah N, Idris T, Awogoke D. Antioxidant effect of zinc, selenium and their combination on the liver and kidney of alloxan-induced diabetes in rats. Mediterr J Nutr Metab 2010; 3: 25-30. [CrossRef]
SebahatTulpar1,Zubeyde Gunduz1, Ugur Sahin2, M. Hakan Poyrazoglu1, Ismail Dursun1, Ruhan Dusunsel1, Funda Bastug1
1Department of Pediatric Nephrology, Erciyes University Faculty of Medicine, Kayseri,Turkey
2Department of Chemistry, Erciyes University Faculty of Arts and Sciences, Kayseri, Turkey
This study was presented at the 5th National Pediatric Nephrology Congress, 9-12 October 2008, Kapadokya, Turkey.
Received: November 26, 2013/Accepted: January 12, 2014/Available Online Date: July 8,2014
Correspondence to: SebahatTulpar, Department of Pediatric Nephrology, Erciyes University Faculty of Medicine, Kayseri, Turkey
Phone: +90 442 232 53 60 e-mail: [email protected]
©Copyright 2014 by the Atatürk University School of Medicine - Available online at www.eajm.org
DOI:10.5152/eajm.2014.36
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Aves Yayincilik Ltd. STI. Oct 2014
Abstract
Trace elements play a significant role in several metabolic processes and often circulate in the blood binding to protein. The purpose of this study was to determine the status of selenium, zinc, and boron in idiopathic nephrotic syndrome patients in active and remission phases. Fourteen patients and fourteen healthy age-matched controls were included in the study. The selenium, zinc and boron level in plasma and urine were measured by the inductively coupled plasma mass spectrometry. The plasma levels of zinc and selenium were significantly lower in both active and remission patients (for all p=0.0001). The plasma boron level was significantly lower only in patients in active phase (p=0.0002 vs control). The concentrations of urinary boron and selenium were significantly higher during active phase compared with remission (p=0.0003 and 0.0001, respectively). Supplementation with zinc, selenium and boron may be justified in patients suffering with this disease.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer